Tumor-infiltrating lymphocytes from human colon carcinomas

This publication has 29 references indexed in Scilit:

• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
  The Journal of Experimental Medicine, 1988
• Human Cytotoxic T Cells Specific for Autologous Melanoma Cells: Successful Generation From Lymph Node Cells in Seven Consecutive Cases
  JNCI Journal of the National Cancer Institute, 1988
• Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.
  The Journal of Experimental Medicine, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986
• A subset of natural killer cells in peripheral blood displays a mature T cell phenotype.
  The Journal of Experimental Medicine, 1986
• Separation, phenotyping and limiting dilution analysis of T‐lymphocytes infiltrating human solid tumors
  International Journal of Cancer, 1986
• Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: Limiting dilution analysis in peripheral blood and at the tumour site
  International Journal of Cancer, 1982